Kazazian Asset Management LLC Acquires New Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Kazazian Asset Management LLC bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, HoldingsChannel reports. The institutional investor bought 31,893 shares of the exchange traded fund’s stock, valued at approximately $2,872,000. SPDR S&P Biotech ETF accounts for approximately 2.2% of Kazazian Asset Management LLC’s holdings, making the stock its 12th biggest holding.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in shares of SPDR S&P Biotech ETF by 198.6% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after purchasing an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter worth $141,284,000. Proficio Capital Partners LLC increased its holdings in shares of SPDR S&P Biotech ETF by 16,156.1% in the 4th quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock worth $82,615,000 after purchasing an additional 911,686 shares in the last quarter. Raymond James Financial Inc. bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter worth $55,529,000. Finally, J.Safra Asset Management Corp increased its holdings in shares of SPDR S&P Biotech ETF by 461.6% in the 4th quarter. J.Safra Asset Management Corp now owns 292,502 shares of the exchange traded fund’s stock worth $26,293,000 after purchasing an additional 240,415 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

XBI stock opened at $86.17 on Wednesday. The company has a market cap of $5.59 billion, a P/E ratio of 11.47 and a beta of 0.99. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The stock’s fifty day moving average price is $89.85 and its 200-day moving average price is $94.58.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.